Selank, a synthetic derivative of tuftsin, activates GABAergic pathways and exhibits anxiolytic properties without sedation
0.16 g/ml, 0.16 ng/ml) and its effect was assessed at the corresponding intervals
Although KPV isnt yet an FDA-approved drug with widespread human use, these practical perspectives have allowed us to deduce its relative position in the larger peptide landscape
While these reports are anecdotal, they align with the peptides known effects on neurotransmitter systems and inflammation
First, side effects are clearly dose-dependent, increasing as the dose goes up
While we have been overwhelmed with inquiries, we would like to note that our current knowledge is limited to the details provided in the linked article